The Joshua Arbesman lab studies genetic mechanisms that place patients at high risk for melanoma development.
The Shideng Bao lab studies glioma stem cell signaling pathways in malignant brain tumors, including glioblastoma.
The Laura Bukavina lab investigates the microbiome's influence on therapeutic outcomes in bladder and kidney cancers.
The Abhishek Chakraborty lab studies oxygen loss and processes oxygen-deprived cancer cells employ for survival.
The Timothy Chan Lab investigates the genomic and immunologic drivers of tumor development and treatment response. We have a special interest in tumor immunology and immunotherapy development.
Dr. Peiwen Chen’s lab studies biological and molecular processes related to primary and metastatic brain cancers.
The Shuyang Chen lab has primary research interests in the environmental and genetic factors contributing to melanoma development.
The Andrew Dhawan lab develops, validates, and implements biomarkers for neuro-oncologic and neuro-genetic diseases.
The Marcela Diaz lab studies the mechanisms that promote or inhibit anti-tumor immune responses and how they could be targeted with immunotherapies.
The Elias Laboratory uses applied mathematics, nanotechnology, and tissue engineering to develop novel tools to diagnose, treat, and prevent ovarian cancer.
The Candece Gladson lab investigates blocking angiogenesis and key molecules that promote survival in malignant glioma tumors.
The Zihua Gong lab studies molecular mechanisms underlying DNA repair pathway choice in breast and ovarian cancers.
The Hannelore Heemers lab explores drug targets for novel, prostate cancer-selective forms of androgen deprivation therapy.
The Babal Kant Jha lab studies the functional basis of cancer-promoting genetic and epigenetic defects to help develop therapeutics.
The Mihriban Kaaraayvaz lab focuses on understanding early events in breast cancer with the goal of identifying individualized therapeutic vulnerabilities.
The Ruth Keri Lab studies breast cancer, focusing on molecularly understanding mammary morphogenesis and carcinogenesis.
The Justin Lathia lab studies how cancer stem cells in glioblastoma interact with their surrounding microenvironment.
The Jeongwu Lee lab studies glioblastoma, focusing on cancer progression and treatment resistance.
The Chao Ma lab works to develop and leverage a multidisciplinary approach that combines engineering with biology and medicine for tissue engineering, disease modeling, and therapy screening.
The McGrail lab uses large-scale data to integrate system-level analyses with controlled experimental models in order to advance precision medicine in oncology and other diseases.
The goal of the Melenhorst lab is to develop potent, safe T cell-based gene therapies for hematologic and solid organ malignancies.
The Jacob Miller lab studies virally-associated neoplasms and develops molecular diagnostics for risk-adapted therapy and early cancer detection.
The Ni lab investigates alterations in metabolism-related genes and metabolites could have direct impact in cancer predisposition, tumor progression and immunotherapy treatment response.
The Rajappa Lab investigates the role of the immune microenvironment in glioma malignant progression and treatment response in addition to developing next-generation precision cellular immunotherapies.
The Reizes lab studies ovarian cancer and triple negative breast cancer, focusing on novel therapeutic development.
The Brian Rubin lab studies the pathogenesis of bone and soft tissue cancers, collectively known as sarcomas.
The Natalie Silver lab is exploring novel ways to reprogram the tumor immune microenvironment to develop therapeutics for head and neck cancers.
The Tiek lab works to better understand metabolic mechanisms that drive drug-resistant gliomas with the goal of creating smarter therapeutics.
The Roberto Vargas lab explores genetic factors that make endometrial carcinoma cells resistant to radiation.
The Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
The Jianjun Wu Lab focuses on understanding the fundamental mechanism of innate immunity and its impact on adaptive immunity, inflammation and cancer.
The Jennifer Yu lab studies glioblastoma and mechanisms underlying stem cell maintenance and therapeutic resistance.
The Jianjun Zhao lab investigates deregulated coding and noncoding genes in the initiation of multiple myeloma.